PSORIASIS (PSO)
Clinical trials for PSORIASIS (PSO) explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS (PSO) trials appear
Sign up with your email to follow new studies for PSORIASIS (PSO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major psoriasis drug trial tests if skin relief lasts
Disease control OngoingThis study is checking if a medication called ESK-001 is safe and keeps working for people with moderate-to-severe plaque psoriasis over a long period. It involves 1,680 adults who have already taken ESK-001 in a previous study. The research will see if the drug's benefits last a…
Matched conditions: PSORIASIS (PSO)
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can a chat with a peer get doctors to prescribe cheaper drugs?
Knowledge-focused OngoingThis study tests if educational visits to doctors change how often they prescribe lower-cost 'biosimilar' versions of a common drug (adalimumab/Humira) for autoimmune diseases. Researchers will compare doctors who receive the educational visit to those who do not, measuring chang…
Matched conditions: PSORIASIS (PSO)
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Could one drug treat two diseases? study on psoriasis and fatty liver link withdrawn
Knowledge-focused TerminatedThis study aimed to understand if there is a connection between non-alcoholic fatty liver disease (NAFLD) and active psoriatic disease (skin/joint inflammation). Researchers wanted to see if a medication called Guselkumab, already approved for psoriasis, could also improve fatty …
Matched conditions: PSORIASIS (PSO)
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC